Deposit $100 to get a $100 trading bonus. Use the promo code AMANAWEB.
Deposit $200 to get a $100 trading bonus.
Use the promo code AMANAWEB.

+4.51%
Today
+4.51%
1D
Sun
Closed
Mon
3:00 AM ~ 12:00 PM
Tue
12:00 AM ~ 12:00 PM
Wed
12:00 AM ~ 12:00 PM
Thu
12:00 AM ~ 12:00 PM
Fri
12:00 AM ~ 12:00 PM
Sat
Closed
Name
Vericel Leveraged
Currency
USD
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0183%
Overnight Fees Sell
0.0016%
Market Cap
2.31B
Avg Daily Volume
600.44K
52 Week High
49.32 USD
52 Week Low
28.95 USD
Trading Hours
See hours
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01830% | $(0.183) |
| SELLS | 0.00160% | $0.016 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Burlington, Massachusetts.
Vericel
+4.51%
Vericel Q2 Earnings Call Highlights
finance.yahoo.com
1w ago

Vericel
+4.51%
VCEL: Record revenue, raised guidance, and a $200M buyback highlight strong growth and cash flow
tradingview.com
1w ago

Vericel
+4.51%
VCEL: Record revenue, raised guidance, and a $200M buyback highlight strong growth momentum
tradingview.com
1w ago

Show more
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.